Counselling, Hypertension, Lifestyle Intervention, Lifestyle Modification
Conditions
Keywords
lifestyle counselling of hypertensive patients, Lifestyle Medicine Assessment Tool
Brief summary
The goal of this clinical trial is to learn if knowing and understanding a patient's daily habits and then giving clear advice on what changes to make can help control blood pressure better than the routine way of advising people with high blood pressure. The main questions it aims to answer are: * To learn if using the Lifestyle Medicine Assessment tool (A 21-item questionnaire) to understand the current lifestyle of people with hypertension and guide them accordingly, helps in lowering blood pressure more, as compared to routine advice? * To see if this way of guiding patients results in more positive lifestyle changes than routine advice? Researchers will compare two groups of people with hypertension. One will be guided after assessing their current lifestyle with the Lifestyle Medicine Assessment Tool and one will be given routine guidance. The researchers will then see which group had better blood pressure control. Participants will be: • Asked a few questions about their lifestyle and then they will be advised accordingly on ways to make it better.
Interventions
The intervention includes using the lifestyle Medicine Assessment Tool (LMA), a 21-item questionnaire, to assess the patient's current lifestyle and deliver structured counselling according to their scores in each domain. To keep the counselling consistent and standardized throughout the study a checklist will be formulated according to the current guidelines on lifestyle modification for hypertensive patients, consisting of counselling items pertaining to each domain, and it will be followed for all patients in the intervention group. This will be repeated at every monthly follow-up visit for three months.
Sponsors
Study design
Eligibility
Inclusion criteria
1. Adult patients aged 18-65 yrs with diagnosed primary/essential hypertension, defined as two or more clinic BP readings of ≥130/80 (ACC/AHA Guidelines). 2. If taking anti hypertensives, then on a stable regime i.e. no recent medication change for at least ≥4 weeks. 3. Willing and able to participate in the study.
Exclusion criteria
1. Diagnosed secondary hypertension. 2. Moderate to severe CKD (eGFR \<60 ml/min/1.73m2). 3. Moderate to severe ischemic heart disease. 4. Diabetes Mellitus requiring insulin. 5. Major psychiatric disorder such as dementia or schizophrenia. 6. Pregnancy or Lactating mother. 7. Unable to participate in study/ Severe mobility limitation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in systolic blood pressure | From enrolment to the end of follow-up at three months | Change in systolic blood pressure from baseline to the third month, measured at monthly intervals. The effect of the intervention will be evaluated as the difference in mean change between the intervention and control groups over time. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in lifestyle factors | From baseline to the three-month follow-up. | Change in lifestyle factors of the control and intervention group, as measured by the total and domain scores of Lifestyle Medicine Assessment Tool. |
Countries
Pakistan